Workflow improvements for enhanced EHR functionality

Utilizing human factor workflow modeling tools, process mapping and goals-means decomposition, a recent report by the National Institute of Standards and Technology unearthed a number of insights on end-user needs to improve EHR workflow for clinicians in outpatient care settings.

The institute offered the following recommendations to improve workflow, with the goals of increasing efficiency, improving eye contact between physicians and patients, reducing alert fatigue and improving physician information workflow:

  • At-a-glance overview displays to enable physicians to adapt patient schedules to smooth out predicted workload and better meet work-life balance objectives
  • Support for remembering tasks to accomplish during a subsequent patient visit
  • Redacting and summarizing laboratory results
  • Drafting predicted orders one day before a patient's visit to reduce time to complete the orders during actual visit
  • Supporting moving from initial working diagnoses to formal diagnoses
  • Supporting dropping or delaying tasks under high workload conditions
  • Supporting different views of a progress note based upon role
  • Distinguishing new documentation in a progress note from copied information from a different progress note
  • Supporting communication with specialist physicians about referrals and consultations
  • Tracking scheduled consults and review of laboratory results

“These recommendations provide a first step in moving from a billing-centered perspective to a clinician-centered perspective where the EHR design supports clinical cognitive work, such as moving from an initial working diagnosis to a formal diagnosis for a complex patient,” wrote the authors. “These recommendations point the way towards a ‘patient visit management system,’ which incorporates broader notions of supporting workload management, and supporting the flexible flow of patients and tasks.”

Read the full report here.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.